Market Research Logo

EyeGate Pharmaceuticals Inc (EYEG) - Product Pipeline Analysis, 2019 Update

Summary

EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontophoresis to deliver optimal therapeutic levels of drug directly into the targeted ocular tissue; and CMHA-S platform is based on hyaluronic acid used in physiological processes such as development, wound healing, tissue homeostasis and joint lubrication. EGP-437, the company’s product in clinical trials, incorporates a reformulated corticosteroid, dexamethasone phosphate which is delivered into the ocular tissues. It also offers drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company EyeGate Pharmaceuticals Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


EyeGate Pharmaceuticals Inc Company Overview
EyeGate Pharmaceuticals Inc Company Snapshot
EyeGate Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
EyeGate Pharmaceuticals Inc – Pipeline Analysis Overview
EyeGate Pharmaceuticals Inc - Key Facts
EyeGate Pharmaceuticals Inc - Major Products and Services
EyeGate Pharmaceuticals Inc Pipeline Products by Development Stage
EyeGate Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status
EyeGate Pharmaceuticals Inc Pipeline Products Overview
EyeGate II Delivery System
EyeGate II Delivery System Product Overview
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy Product Overview
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy Clinical Trial
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies Product Overview
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies Clinical Trial
EyeGate Pharmaceuticals Inc - Key Competitors
EyeGate Pharmaceuticals Inc - Key Employees
EyeGate Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
EyeGate Pharmaceuticals Inc, Recent Developments
Jun 03, 2019: Eyegate receives approval from FDA to initiate PRK pivotal study
May 08, 2019: EyeGate Pharma reports first quarter 2019 financial results and provides business update
May 02, 2019: EyeGate files IDE with FDA for PRK pivotal study
Mar 26, 2019: EyeGate confirms path to de novo filing with FDA
Mar 01, 2019: EyeGate Pharmaceuticals reports full Year 2018 financial results and provides business update
Jan 16, 2019: EyeGate Pharmaceuticals announces meeting date with FDA
Nov 13, 2018: EyeGate Pharmaceuticals reports third quarter 2018 financial results and provides business update
Nov 13, 2018: EyeGate Pharma announces positive results in second PRK study
Sep 24, 2018: EyeGate Pharmaceuticals completes enrollment in both PRK and PE pilot studies
Sep 04, 2018: EyeGate announces top-line results for phase 3 trial of EGP-437 in anterior uveitis
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
EyeGate Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
EyeGate Pharmaceuticals Inc Pipeline Products by Equipment Type
EyeGate Pharmaceuticals Inc Pipeline Products by Indication
EyeGate Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status
EyeGate Pharmaceuticals Inc, Key Facts
EyeGate Pharmaceuticals Inc, Major Products and Services
EyeGate Pharmaceuticals Inc Number of Pipeline Products by Development Stage
EyeGate Pharmaceuticals Inc Pipeline Products Summary by Development Stage
EyeGate Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status
EyeGate Pharmaceuticals Inc Ongoing Clinical Trials Summary
EyeGate II Delivery System - Product Status
EyeGate II Delivery System - Product Description
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy - Product Status
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy - Product Description
EyeGate Ocular Bandage Gel - Photorefractive Keratectomy - A Randomized Masked (Reading Center), Controlled, Prospective Pivotal Study of the Effectiveness and Safety of the Eyegate Ocular Bandage Gel, A .75% Crosslinked Hyaluronic Acid (HA) Applied Topically, Versus a Bandage Contact Lens (BCL) in Accelerating Re-epithelialization of Large Corneal Epithelial Defects in Patients Having Undergone Photorefractive Keratectomy (PRK)
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies - Product Status
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies - Product Description
EyeGate Ocular Bandage Gel - Punctate Epitheliopathies - Study to Assess the Effectiveness of Ocular Bandage Gel (OBG) in Subjects with Punctate Epitheliopathies (PE)
EyeGate Pharmaceuticals Inc, Key Employees
EyeGate Pharmaceuticals Inc, Subsidiaries
Glossary
List of Figures
EyeGate Pharmaceuticals Inc Pipeline Products by Equipment Type
EyeGate Pharmaceuticals Inc Pipeline Products by Development Stage
EyeGate Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook